Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-022540

Chief Financial Officer sold 1,918 shares at an average $50.80 ($97,441)

  • Chief Financial Officer acquired 6,407 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Smith Hunter C Chief Financial Officer 2024-02-09 Option exercise +4,063 79,278 D
Smith Hunter C Chief Financial Officer 2024-02-11 Option exercise +2,344 81,622 D
Smith Hunter C Chief Financial Officer 2024-02-12 Sale −1,209 $51.38 $62,118 80,413 D
Smith Hunter C Chief Financial Officer 2024-02-13 Sale −709 $49.82 $35,322 79,704 D
Derivatives
Smith Hunter C Chief Financial Officer 2024-02-09 Option exercise · Restricted Stock Units −4,063 8,124 D
Smith Hunter C Chief Financial Officer 2024-02-11 Option exercise · Restricted Stock Units −2,344 2,343 D
Open-market sales · 1,918 sh · avg $50.80 · $97,441
Loading xslF345X05/tm246165-5_4seq1.xml…